2008
Pacemaker Therapy for Early and Late Sinus Node Dysfunction in Orthotopic Heart Transplant Recipients: A Single‐Center Experience
LUEBBERT JJ, LEE FA, ROSENFELD LE. Pacemaker Therapy for Early and Late Sinus Node Dysfunction in Orthotopic Heart Transplant Recipients: A Single‐Center Experience. Pacing And Clinical Electrophysiology 2008, 31: 1108-1112. PMID: 18834460, DOI: 10.1111/j.1540-8159.2008.01149.x.Peer-Reviewed Original ResearchConceptsOrthotopic heart transplantationSinus node dysfunctionOHT recipientsEarly complicationsTransplant recipientsLate sinus node dysfunctionSignificant sinus node dysfunctionOrthotopic heart transplant recipientsHeart transplant clinicMean age 50.2Heart transplant recipientsSingle-center experienceAge 50.2Electrophysiology serviceTransplant clinicHeart transplantationHeart transplantPermanent pacemakerLikely multifactorialPacemaker therapyLarge cohortPatientsAmbulatory monitoringRecipientsPacemaker
2004
Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure
Upadya S, Lee FA, Saldarriaga C, Verma S, Sedrakyan A, Nystrom K, Katz SD. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure. The Journal Of Heart And Lung Transplantation 2004, 23: 466-472. PMID: 15063407, DOI: 10.1016/s1053-2498(03)00203-1.Peer-Reviewed Original ResearchConceptsPositive inotropic therapyInotropic therapyCardiac transplantationFunctional capacityDecreased health care costsEnd-stage heart failureImplantable cardioverter-defibrillator dischargeHome therapy patientsStatus 1B patientsInitiation of therapyStable clinical statusNumber of hospitalizationsPre-treatment baselineImplantable cardioverter defibrillatorHealth care costsActuarial survivalInotropic treatmentRenal functionConsecutive patientsHeart failureClinical statusHemodynamic monitoringHome infusionInotropic infusionUnited Network
2000
The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular function
Rose M, Lee F, Gollerkeri A, D'Andrea E, Psyrri A, Bdolah-Abram T, Burtness B. The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular function. Bone Marrow Transplantation 2000, 26: 133-139. PMID: 10918422, DOI: 10.1038/sj.bmt.1702449.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCombined Modality TherapyCyclophosphamideDoxorubicinFemaleFollow-Up StudiesHematopoietic Stem Cell MobilizationHematopoietic Stem Cell TransplantationHumansMiddle AgedNeutropeniaPaclitaxelStroke VolumeSurvival RateVentricular Dysfunction, LeftConceptsLeft ventricular ejection fractionHigh-dose chemotherapyBreast cancer patientsMean absolute decreaseCancer patientsAbsolute decreaseLV functionCell rescueImpaired left ventricular functionHigh-dose thiotepaImpaired LV functionHigh-dose melphalanStem cell rescueSymptomatic heart failureCourses of chemotherapyVentricular ejection fractionLeft ventricular functionSequential paclitaxelMetastatic diseaseCardiac deathCardiac symptomsEjection fractionHeart failureVentricular functionCardiac toxicity